FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Asclemed Lidocaine HCl Injection Recall

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distribut…

Asclemed USA Inc. · Torrance, CA

Risk level
Class II
Reported by FDA
Jul 8, 2026
Recall ID
D-0659-2026
Check your lot numberHow we source this data

Summary

Asclemed recalled Lidocaine HCl Injection starting Jun 8, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0659-2026 on Jul 8, 2026. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.

Lot numbers, UPCs & expiration codes

Lot #: AE3102, 031926L01, 032026A01, Exp 11/30/2026; AE5052, 052026G01, Exp 04/30/2028.

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0659-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 8, 2026
FDA report date
Jul 8, 2026
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Asclemed USA Inc.

Original FDA data

Every field from FDA enforcement report D-0659-2026, exactly as published.

Show all FDA fields
City
Torrance
State
CA
Status
Ongoing
Country
United States
Event ID
99204
Address
379 Van Ness Ave Ste 1403
Code information
Lot #: AE3102, 031926L01, 032026A01, Exp 11/30/2026; AE5052, 052026G01, Exp 04/30/2028.
Postal code
90501-7211
Report date
Jul 8, 2026
Product type
Drugs
Recall number
D-0659-2026
Classification
Class II
Recalling firm
Asclemed USA Inc.
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.
Distribution pattern
USA Nationwide
Recall initiation date
Jun 8, 2026
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jul 2, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0659-2026, published Jul 8, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls